Overview

High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors

Status:
Terminated

Trial end date:
2012-04-24

Target enrollment:

Participant gender:

Summary

This is a study of amifostine to determine how effective it is in the reduction of infection in a high dose chemotherapy regimen with autologous stem cell rescue in children with high risk, relapsed or refractory pediatric solid tumors.

Phase:

Phase 2

Details

Lead Sponsor:

Children's Hospital Medical Center, Cincinnati

Treatments:

Amifostine